A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflazine) in the Treatment of Comatose Survivors of Cardiac Arrest
Open Access
- 2 May 1991
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (18), 1225-1231
- https://doi.org/10.1056/nejm199105023241801
Abstract
Abnormalities of cellular calcium homeostasis have been implicated in the pathophysiology of postischemic encephalopathy. Calcium-entry—blocking drugs inhibit the influx of calcium into cells and have been shown to mitigate postischemic encephalopathy in animal models.This publication has 39 references indexed in Scilit:
- The effects of nicardipine given after 10-minutes complete global cerebral ischemia on neurologic recovery in dogsJournal of Anesthesia, 1990
- Deferred consent: Use in clinical resuscitation researchAnnals of Emergency Medicine, 1990
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.Stroke, 1986
- Randomized Clinical Study of Thiopental Loading in Comatose Survivors of Cardiac ArrestNew England Journal of Medicine, 1986
- Ischemic brain injury and cell calcium: Morphologic and therapeutic aspectsAnnals of Emergency Medicine, 1985
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogsAnnals of Emergency Medicine, 1983
- The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia.Stroke, 1982
- Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.Circulation, 1981